Joe Larsen's guest appearances

Joe Larsen

Doing It At Home - The Home Birth Podcast

Pharma Intelligence Podcasts

Hella Controversial

Scott Whitaker

Jill Miller

Debbie Schneider

Mike Ward

Chris Porter

Amy Brown

Jeff Allen

Sarah Buckley

Lily Nichols

Arianna Taboada

Lisa Hendrickson-Jack

Afua Hassan

David Spangler

Joe Jimenez

Ben Marshall

OwlTail

We get into small little controversies and you learn a little about the Larsen’s and our opinions. Hope you enjoy this fun little FIRST episode! --- This episode is sponsored by · Anchor: The easiest way to make a podcast.  https://anchor.fm/app

We get into small little controversies and you learn a little about the Larsen’s and our opinions. Hope you enjoy this fun little FIRST episode! --- This episode is sponsored by · Anchor: The easiest way to make a podcast. <a href="https://anchor.fm/app" rel="nofollow" target="_blank">https://anchor.fm/app</a>

Cheetos or Doritos with My husband, Joe Larsen

In this episode I chat with Brianna and Joe Larsen about their second birth, and they did it at home! This birth was the opportunity to fulfill a deep desire for a home birth self-empowerment for Brianna. And get this - Joe himself is a home birth baby! So bringing a more holistic approach and trust in the way God designed our bodies, he was in full support of the process. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode I chat with Brianna and Joe Larsen about their second birth, and they did it at home! This birth was the opportunity to fulfill a deep desire for a home birth self-empowerment for Brianna. And get this - Joe himself is a home birth baby! So bringing a more holistic approach and trust in the way God designed our bodies, he was in full support of the process. Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices" rel="nofollow" target="_blank">megaphone.fm/adchoices</a>

108: HOME BIRTH STORY - Fulfilling the Deep Desire to Have a Home Birth with Brianna and Joe Larsen

Kevin Outterson

CARB-X Executive Director Kevin Outterson and BARDA Acting Deputy Director Joe Larsen describe the work of the accelerator, which announced the first eleven projects in its Powered by CARB-X portfolio March 30.                 The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X, announced the first eleven projects in its Powered by CARB-X portfolio March 30. Details on each of the initial projects are here: http://www.carb-x.org/portfolio; they include three projects on new classes of antibiotics and four projects on non-traditional products, such as immunotherapy or antibody-drug candidates.  We talked to Executive Director Kevin Outterson narrowing down applicants from the wide interest and upcoming additions to the portfolio. Then BARDA Deputy Director Joe Larsen discussed the beginning of CARB-X, how it fits with other work by BARDA and how the accelerator could also make private investment attractive again in this space. Both emphasized the continued need for pull incentives, such as wildcard patent exclusivity or market entry rewards.

CARB-X Executive Director Kevin Outterson and BARDA Acting Deputy Director Joe Larsen describe the work of the accelerator, which announced the first eleven projects in its Powered by CARB-X portfolio March 30. The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X, announced the first eleven projects in its Powered by CARB-X portfolio March 30. Details on each of the initial projects are here: <a href="http://www.carb-x.org/portfolio;" rel="nofollow" target="_blank">http://www.carb-x.org/portfolio;</a> they include three projects on new classes of antibiotics and four projects on non-traditional products, such as immunotherapy or antibody-drug candidates. We talked to Executive Director Kevin Outterson narrowing down applicants from the wide interest and upcoming additions to the portfolio. Then BARDA Deputy Director Joe Larsen discussed the beginning of CARB-X, how it fits with other work by BARDA and how the accelerator could also make private investment attractive again in this space. Both emphasized the continued need for pull incentives, such as wildcard patent exclusivity or market entry rewards.

Accelerating Antibiotics: Kevin Outterson and Joe Larsen on CARB-X